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Double Robust Estimation in Longitudinal
Marginal Structural Models
Zhuo Yu and Mark J. van der Laan
Abstract
Consider estimation of causal parameters in a marginal structural model for the
discrete intensity of the treatment specific counting process (e.g. hazard of a treat-
ment specific survival time) based on longitudinal observational data on treat-
ment, covariates and survival. We assume the sequential randomization assump-
tion (SRA) on the treatment assignment mechanism and the so called experimen-
tal treatment assignment assumption which is needed to identify the causal pa-
rameters from the observed data distribution. Under SRA, the likelihood of the
observed data structure factorizes in the auxiliary treatment mechanism and the
partial likelihood consisting of the product over time of conditional distributions
of covariate and survival at a specific time, given the past. Due to the curse of
dimensionality, without assuming lower dimensional models for either the par-
tial likelihood or the treatment mechanism, there exist no regular asymptotically
linear estimators with reasonable practical performance (van der Laan and Robins
[2002]). In this article, we define three estimators the Inverse Probability of Treat-
ment weighted (IPTW) estimator based on a maximum likelihood estimator of the
treatment mechanism according to a model, the maximum likelihood estimator
(MLE) based on a maximum likelihood estimator of the partial likleihood accord-
ing to a model, and a double robust (DL) estimator based on the maximum likeli-
hood estimator of the treatment mechanism and the maximum likelihood estimator
of the partial likelihood. The double robust estimator is obtained by following a
general methodology for constructing double robust estimating functions in cen-
sored data models as described in van der Laan and Robins [2002]. We propose
specific implementation of this estimator based on Monte-Carlo simulation meth-
ods, which makes the estimator computationally tractable and maximally robust.
The double-robust estimator is consistent and asymptotically linear when either
the treatment mechanism or the partial likelihood of the observed data is consis-
tently estimated. We extend the estimator to handle informative censoring. We
illustrate the practical performance of the DR estimator relative to the IPTW and
ML estimators in a simulation study. The proposed methodology is also applied
to estimate the causal effect of exercise on physical functioning in a longitudinal
study of seniors in Sonoma County.
1 Introduction
It is important to point out why conventional approaches for estimating causal effects
of time-dependent treatment will not produce valid results for longitudinal data struc-
tures. The most common method for handling confounders is to adjust for them or, in
other words, to include all confounders in the regression model. In a point-treatment
study, the resulting regression coefficient for the treatment does indeed have a causal
interpretation. However, in a longitudinal study where the treatment changes over
time – possibly in response to observed confounders, which are also affected by past
treatment – such a regression has no causal interpretation, even if the assumption of no
unmeasured confounders holds and the regression model is correctly specified. Another
reason to look beyond the usual approach is the need to describe treatment effects for
large diverse populations, for example, in policy-making. We may be truly interested
the marginal effect of treatment on a population, as opposed to the treatment effect
conditional on the values of certain covariates.
Marginal Structural models (MSMs) model causal effect of a time-dependent treat-
ment on the distribution of treatment specific counterfactual outcomes of interest. Un-
der the sequential randomization and the experimental treatment assignment assump-
tion, these marginal structural models are identified from the observed data distribu-
tion. Robins et al. [2000] proposes inverse-probability-of-treatment weighted (IPTW)
estimators of the unknown parameters of the MSM. The IPTW estimator is consistent
if the treatment mechanism is correctly specified. In subsequent work Robins [2000b],
proposes a double robust estimation methodology to estimate causal parameters in
marginal structural models, whose consistency relies on either consistent estimation
of the treatment mechanism or on consistent estimation of regressions. The assumed
working models for the regressions cannot be expected to be compatible with a data
generating distribution, and therefore Robins [2000b] refers to the corresponding es-
timators as generalized double robust estimators. In this article we develop a double
robust (DR) estimator whose consistency relies on consistent estimation of either the
treatment mechanism or the partial likelihood.
If both treatment mechanism and partial likelihood are correctly specified, the DR
estimator is more efficient than the IPTW estimator. In practice, even when the treat-
ment mechanism is consistently estimated, if one uses a small working model for the
partial likelihood, then the double robust estimator is typically more efficient, except
at extreme misspecification of the working model. We carry out a simulation study to
demonstrate the performance of the DR estimator relative to the inverse-probability-
of-treatment (IPTW) and the maximum likelihood estimator (MLE) maximizing the
partial likelihood. The method is also generalized to the case where there is informative
censoring. We use the methodology to estimate the effect of an activity score on the
physical functioning for women enrolled in an observational study entitled “Study of
Physical Performance and Age Related Changes in Sonomans” (SPARCS) Tager et al.
[2000a].
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1.1 The observed data model
The theory of counterfactual causal inference in longitudinal studies is first laid out in
Robins [1986, 1987b, 1989, 1997]. Let time t take values in τ = [0, T ], where T is a finite
fixed number. For a time-dependent process t → Z(t), we denote its sample path up
to time t∗ with Z¯(t∗) = {Z(t) : t ≤ t∗} and its complete sample path by Z¯ = Z¯(T ) =
{Z(t) : t ∈ τ}. In this paper, we divide τ = [0, T ] into K + 1 intervals of equal length.
Therefore, time is discrete and takes values in τ = {0 = t0, t1, . . . , tK , tK+1 = T}. For
any time-dependent process, we will at times use the abbreviated notation Zk and Z¯k
in place of Z(tk) and Z¯(tk).
Let t → A(t) be a time-dependent treatment process on [0, tK ] and letA be the set of
possible sample paths of A¯, where we assume that A is finite. Let Xa¯(·) ≡ (Ya¯(·), La¯(·))
be the counterfactual outcome and covariate process over time t ∈ [0, T ] under treat-
ment regime a¯. Let Sa¯ be a treatment specific survival time which is part of X¯a¯. For
example, if survival is the outcome of interest, then one will have Ya¯(t) = I(Sa¯ ≤ t).
We truncate all counterfactual processes at Sa¯, that is, Xa¯(t) = Xa¯(min(t, Sa¯)). In
time sequence the complete history of the subject counterfactual results is given by
La¯(t0), Ya¯(t0), a0 . . . , La¯(tK), Ya¯(tK), aK , La¯(tK+1), Ya¯(tK+1).
We will denote the baseline (pretreatment) covariates with W = La¯(t0) = L(t0) which
are not affected by the treatment regime. For each possible treatment regime a¯, X¯a¯(tk)
represents the data one would observe on the subject up to time tk, if the subject were
to follow treatment regime a¯. The complete sample path X¯a¯ is a counterfactual and is
comprised of the paths of the outcome process Y¯a¯, the covariate process L¯a¯. We assume
X¯a¯(tk) = X¯a¯(tk−1)(tk). The full data for a subject is the collection of counterfactuals Xa¯
generated by allowing treatment to range over the entire space A, that is:
X = (Y¯a¯, L¯a¯ : a¯ ∈ A)
Let A¯, given X, follow a conditional density which is such that
g(A(tk) | A¯(tk−1), X) = I(SA¯ ≤ tk)I(A(tk) = A(tk−1))+I(SA¯ > tk)g(A(tk) | A¯(tk−1), X).
In words, we truncate the treatment process at death.
The observed data is a missing data structure given by
O = (A¯, X¯A¯) = (A¯, Y¯A¯, L¯A¯).
We see that the observed data is the observed treatment regime A¯ and the correspond-
ing single counterfactual XA¯. If X ∼ FX and A | X has density g(· | X), then we
denote the corresponding distribution of O with PFX ,g.
To acknowledge that the data collection stops deterministically after S = SA¯, one
can also represent O as
O = (A¯(S), Y¯ (S), L¯(S).
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If S exceeds T , then we note that each of these processes is truncated at T in the sense
that (e.g.) L(t) = L(min(t, T )).
Let V ⊂ W be a selected subset of the baseline covariates for which one wishes to
adjust the treatment specific intensity of Ya¯. We assume a marginal structural intensity
model for the process Ya¯(·):
E(dYa¯(tk)|Y¯a¯(tk−1), V ) = λ(tk, a¯k−1, Y¯a¯(tk−1), V |α), (1)
where λ(tk, a¯k−1, Y¯a¯(tk−1), V |α) is a known function, up to a p-dimensional parameter
α. Our goal is to estimate α based on n i.i.d. copies (O1, O2, . . . , On) of O.
As an example consider a study designed to determine the causal effect of a time-
dependent treatment on survival or, alternatively, the hazard of mortality. Let Ya¯(tk)
be a counting process that indicates the occurence of death in the interval (tk−1, tk),
where Ya¯(t0) is 0 for all a¯ ∈ A by definition. The survival time can be recovered
from the path Y¯a¯, up to the resolution permitted by discrete time. A subject’s record
continues until failure. In this case λ(·|α) is the product of an indicator that the
subject is at risk for the event of interest and a function pi:
λ(tk, a¯k−1, Y¯a¯(tk−1), V |α) = I(Ya¯(tk−1) = 0)× pi(tk, a¯k−1, V |α), (2)
where pi(tk, a¯k−1, V |α) might be a logistic function logit−1 (α0 + α1tk + α2ak−1 + α3V ).
The choice of V (e.g. V =) depends on what the parameter of interest is and is therefore
determined by the scientific question. For example, in policy making one might elect
not to adjust for baseline covariates.
We adopt the framework of Bryan, Yu, van der Laan (2002), by not treating all
timepoints tk as equal, but in terms of the actions taken and the information collected.
Continuing the above example, the potential failure times tk will be called monitoring
times. The interval length tk−tk−1 will generally be quite small and corresponds to the
resolution with which we record survival time, for example, up to the month of death.
At a given subset of the monitoring times, which we call the measuring times, we
observe the covariate process L(tk). These measuring times generally coincide with a
regular assessment such as a medical check-up. Typically, the treatment Ak can change
at these measuring times, but one can also imagine situations in which the treatment
changes at even fewer time points. We call these treatment times, which are a subset
of the measuring times, which are a subset of the monitoring times. Schematically, at
a time tk, here is what happens for a subject:
1. Determine the outcome Yk, i.e. confirm that subject survived the interval (tk−1, tk).
2. If tk is a measuring time, measure the covariate Lk, otherwise assign it the same
value as L(tk−1).
3. If tk is a treatment time, assign the treatment Ak for the next time interval,
otherwise assign it the same value as A(tk−1).
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In order to identify causal effects, we must assume that the probability of a partic-
ular treatment decision at a treatment time tk only depends on the observed history
(A¯k−1, Y¯k, L¯k,W ) = (A¯k−1, X¯A¯(tk)) of the subject. This assumption is called the se-
quential randomization assumption (SRA). To formally define the SRA, we recall the
full data for a subject: X = (X¯a¯ : a¯ ∈ A). The treatment mechanism satisfies SRA if
g(A¯|X) = g(A0|X)
K∏
k=1
g(Ak|A¯k−1, X)
= g(A0|X¯A¯(t0))
K∏
k=1
g(Ak|A¯k−1, X¯A¯(tk))
(3)
In other words, conditional on the observed past, the treatment decision at time tk is
independent of the full set of counterfactual data X [Robins, 1997]. This assumption
is also referred to as the assumption of no unmeasured confounders.
Under SRA, the observed data likelihood w.r.t. an appropriate dominating measure
is given by
p(O) =
K∏
j=1
p(Yj|Y¯j−1, L¯j , A¯j)p(Lj|Y¯j−1, L¯j−1, A¯j−1)× g(A¯|X)
≡QX(O)g(A¯|X),
(4)
where p represents a conditional density. We denote the first part of p(O) with QX
which is the FX part of the likelihood since
QX(A¯,XA¯) = pXa¯(XA¯))a¯=A¯
is the marginal density of the counterfactual distribution of Xa¯ with a¯ = A¯. This
relation between the observed data likelihood QX and the counterfactual distributions
is also referred to as the G-computation formula for the density of X¯a¯ Robins [1987a].
More general, it is a consequence of the general factorization of the likelihood of a
censored data structure under coarsening at random (as implied by SRA), as proved
by Heitjan and Rubin [1991]), Jacobsen and Keiding [1995], and Gill et al. [1997] in
increasing generality. The discrete version of the G-computational formula is first given
by Robins [1987a]. Continuous versions of the G-computation formula are proved in
Gill and Robins [2001] and Yu and van der Laan [2002].
Consistent estimation of the causal parameter α requires consistent estimators of
either the partial likelihood QX or the treatment mechanism g (van der Laan, Robins,
2002). Due to the curse of dimensionality, this means that we will also need to as-
sume a lower dimensional model for either the partial likelihood QX or the treatment
mechanism or both.
1.2 Overview.
In the next section we define three estimators: the Inverse Probability of Treatment
weighted (IPTW) estimator based on a maximum likelihood estimator of the treatment
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mechanism according to a model, the maximum likelihood estimator (MLE) based on
a maximum likelihood estimator of the partial likelihood according to a model, and
a double robust (DL) estimator based on the maximum likelihood estimator of the
treatment mechanism and the maximum likelihood estimator of the partial likelihood.
The double robust estimator is obtained by following a general methodology for con-
structing double robust estimating functions in censored data models as described in
van der Laan and Robins [2002]. We propose specific implementation of this estimator
based on Monte-Carlo simulation methods, which make the estimator computationally
tractable and maximally robust. The double-robust estimator is consistent and asymp-
totically linear when either the treatment mechanism or the partial likelihood of the
observed data is consistently estimated. For both the IPTW and the DR estimators,
we provide confidence intervals for α. In section 3 we extend the approach to handle
right censored data.
Bryan, Yu and Laan [2002] also studied a one-step estimator and showed that
it is superior to the IPTW estimator in terms of efficiency. The one-step estimator
corresponds with the first step of the Newton-Raphson algorithm for solving the double
robust estimating function when starting with the IPTW estimator. Consequently,
though, the one-step estimator is very easy to compute, it is not doubly robust.
In order to compare the practical performance of the estimators under consideration,
we present the results of a simulation study in section 4. Our results show that the DR
estimator can be far more efficient than the IPTW estimator and that it is far more
robust than the IPTW and maximum likelihood estimator. Finally, in section 5, we
apply the extended methodology to estimate the causal effect of exercise on mortality
in a longitudinal study of seniors in Sonoma County.
2 Estimation and Inference
2.1 The IPTW estimator
In this subsection we describe the first of three estimators of α: the IPTW estimator.
An IPTW estimator is obtained as the solution of an estimating equation and the
relevant estimating function results from a mapping of full data estimating functions
into observed data estimating functions. The details of the IPTW mapping and a proof
that the TSRA orthogonalized IPTW mapping, as presented in the next subsection,
produces the class of all observed data estimating functions is provided in van der
Laan and Robins [2002].
Let
a¯(tk | α) ≡ Ya¯(tk)− λ(tk, a¯k−1, Y¯a¯(tk−1), V |α)
and let A¯(· | α) be the observed vector of residuals. Let h(·) be any function of
time, the selected baseline covariates V , and the observed history of the treatment and
outcome processes; a typical choice of h is given by (8). For every h, we can define an
5
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IPTW estimating function ICiptw(O|g,α, h):
ICiptw(O|g,α, h) =
∑
k
sw(tk)× h(tk, A¯k−1, Y¯k−1, V )× A¯(tk | α)
=
∑
k
( k∏
j=0
g(Aj |A¯j−1, V )
g(Aj |A¯j−1, X¯A¯(tj))
)
× h(tk, A¯k−1, Y¯k−1, V )× A¯(tk | α).
(5)
This has the familiar form of generalized estimating functions for the regression model
corresponding with the marginal structural model, namely, a sum over time of time-
specific products of a residual and a function of the covariates. However in this case, we
additionally have stabilized time-specific weights sw(tk) that capture the probability of
the observed treatment given the past. In practical terms, any IPTW-type estimator
works by upweighting (downweighting) subjects that, given their observed past, have
received an unusual (typical) treatment. This is achieved through the use of weights
inversely proportional to the probability of the observed treatment, given the covariate.
The stabilized weights sw(tk) in (5) [Robins, 1998] include a numerator term that, in the
absence of time-dependent confounding, will equal the denominator and will produce an
unweighted estimating function. In the presence of confounding the stabilized weights
cause the estimating function to remain unbiased. Formally, if
g(a∗|A¯j−1, X¯(j)) > 0 for all a∗ ∈ {aj : a¯j−1 = A¯j−1, a¯ ∈ A}, (6)
then EPFX ,gICiptw(O | g,α(FX), h) = 0.
This latter (so called) experimental treatment assignment assumption is a condition
on the support of g(· | X). It could be seriously violated and thereby make the IPTW
estimating function heavily biased. In addition, even when this assumption holds
theoretically, but the probabilities on certain a∗ are almost equal to zero, then this
so called practical violation of the ETA (that is, given the finite sample size, the
support of g(· | X) is truly restricted) will cause serious finite sample bias of the
corresponding IPTW estimator. We refer to Neugebauer and van der Laan [2002], and
van der Laan and Robins [2002] for a detailed explanation and practical illustration.
For example, suppose aj is a dichotomous variable and P (Aj = 1|Aj−1, X¯(j − 1)) =
expit(θ0 + θ1Aj−1 + θ2X(j − 1)), where expit(x) ≡ exp(x)/(1 + exp(x)). If θ2 is very
large, then for certain values of X(j − 1), the probability that Aj is zero is so small
that it does not happen for the given sample size.
Since the treatment mechanism g is typically unknown, it represents a nuisance pa-
rameter of the IPTW estimating function. We can estimate g with maximum likeihood
estimation according to a lower dimensional parametric or semiparametric model for
g(Aj |A¯j−1, X¯A¯(tj)). Let gn denote such a maximum likelihood estimator of the treat-
ment mechanism. Let α̂iptwn (the IPTW estimator) be defined as the solution of the
following estimating equation
n∑
i=1
ICiptw(Oi|gn, α̂iptwn , h) = 0. (7)
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Regarding the choice of h, we will make the usual choice for h, namely, the optimal
choice for the regression model corresponding with the MSM. [Robins, 2000a, Hernan
et al., 2000]:
h(tk, A¯k−1, Y¯k−1, V ) =
d
dα
λ(tk, A¯k−1, Y¯a¯(tk−1), V |α). (8)
Standard software can be employed to solve the weighted estimating equation implied
by (8). Practical details for implementing this particular IPTW estimator are provided
in Bryan et al. [2002].
2.2 Maximum Likelihood Estimator
In this section we provide a second estimator of α, a Maximum Likelihood (ML) estima-
tor assuming a model for the partial likelihoodQX(A¯,XA¯). Let PLk+1|A¯k,Y¯k,L¯k(dlk+1; a¯k, y¯k, l¯k)
and PYk+1|A¯k+1,Y¯k,L¯k+1(dyk+1; a¯k, y¯k, l¯k+1) be the regular conditional distributions for
Lk+1 given (A¯k, Y¯k, L¯k) and Yk+1 given (A¯k+1, Y¯k, L¯k+1) respectively. If the experi-
mental treatment assumption (6) holds, then
P (Ya¯(tj) ∈ dyj) =
∫
l1
∫
y1
. . .
∫
yj−1
∫
lj
j−1∏
k=0
PYk+1|A¯k+1,Y¯k,L¯k+1(dyk+1; a¯k+1, y¯k, l¯k+1)
×
j−1∏
k=0
PLk+1|A¯k,Y¯k,L¯k(dlk+1; a¯k, y¯k, l¯k).
(9)
Given the partial likelihood QX , Robins (1987a) proposes to evaluate this distribution
of the counterfactual process Ya¯(·) by drawing a large sample with the following Monte-
Carlo simulation algorithm. An asterix is used to denote simulated variables. Given a
treatment regime a¯ ∈ A, one first generates L∗1 = l∗1 from the marginal distribution of
L1. Subsequently, one generates Y
∗
1 = y
∗
1 from the conditional distribution of Y1 given
L1 = l
∗
1, A1 = a1. Then one generates l
∗
2 from the conditional distribution of L2 given
L1 = l
∗
1, A1 = a1, Y1 = y
∗
1; and so on. This provides us with a draw (y
∗
1, . . . , y
∗
K) from
the distribution of Y¯a¯ described by (9). By drawing a large number of realizations, one
obtains an arbitrarily good approximation of the distribution of Y¯a¯.
Since QX is unknown, we will estimate it with maximum likelihood estimation
according to a model. The conditional density of Yj given the past can be estimated by
assuming a parametric model pθ(Yj|Y¯j−1, L¯j, A¯j) and then estimating θ with the MLE.
Similary we can estimate the conditional density for Lj given the past. Substituting this
fit of the partial likelihood QX into the formula (9) provides us now with an estimate
of the counterfactual distribution of Ya¯ for each a¯ ∈ A.To determine the corresponding
estimate of the causal parameter α, we now apply the above Monte-Carlo algorithm
to generating a large sample of Yˆa¯(tK) for a rich collection of treatment regimes a¯’s.
Finally, we fit our marginal structural model (1) to this large sample on (Ya¯, a¯) with
standard software. For example, if our MSM is the logistic regression model, then by
regressing simulated y∗a¯(tj) on tj and aj using logistic regression, treating the pooled
7
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sample as an i.i.d. sample, we obtain an estimate of α. We note that the model we
assume for QX may not be compatible with our MSM. In that case, the above method
determines the fit of the MSM most compatible with QX .
2.3 Double Robust Estimator
In this section we provide the third estimator of α, namely, the Double Robust (DR)
estimator α̂drn . The general proposal for Double Robust estimation in censored data
models such as our causal inference model is provided in Secion 1.6 of van der Laan and
Robins [2002]. The double robust estimating functions are defined by subtracting from
the IPTW estimating functions the projection onto a nuisance tangent space TSRAof
the treatment mechanism in the Hilbert space L20(PFX ,g). Formally, TSRA is defined
as the Hilbert space of all the nuisance scores corresponding with one-dimensional
submodels through the true treatment mechanism with the only restriction being that
these submodels need to satisfy the SRA. Though not important for following this
section, we also remind the reader that L20(PFX ,g) is the Hilbert space consisting of all
functions of the observed data structure O = (A¯,XA¯) ∼ PFX ,g with mean zero and
finite variance endowed with inner product 〈h1, h2〉PFX ,g = EFX ,gh1(O)h2(O).
It will be convenient in this and later sections to define Fk ≡ (A¯k−1, Y¯k, L¯k); in
words, Fk is the observed past just prior to the treatment assignment Ak. The tangent
space for the treatment mechanism nuisance parameter at time tk, denoted TSRA,k, is
the space of scores obtained by varying g(Ak|Fk). This is the space of all functions of
Ak and Fk that have conditional mean zero, given the observed past Fk. That is, for
dk ranging over all functions of Ak and Fk we have that
TSRA,k = {dk(Ak,Fk)− Eg(dk(Ak,Fk)|Fk) : dk} , k = 0, . . . , K (10)
The factorization of g(A¯|X) into time-specific terms implies that
TSRA = TSRA,0 ⊕ TSRA,1 ⊕ . . .⊕ TSRA,K
=
{
K∑
k=0
dk(Ak,Fk)− E(dk(Ak,Fk)|Fk)(d1, . . . , dK)
}
. (11)
That is TSRA is the orthogonal sum of TSRA,k, k = 0, . . . , K
We obtain a DR estimating function from the IPTW estimating function
ICiptw(O|g,α, h) by subtracting its projection onto TSRA. The projection of
ICiptw(O|g,α, h) onto TSRA is given by
ICSRA(O|QX , g) =
K∑
k=0
EQX ,g(ICiptw(O|g,α(QX), h)|Ak,Fk)
− EQX ,g(ICiptw(O|g,α(QX), h)|Fk),
(12)
We note that ICSRA(O|QX , g) is only a function of QX and g since the observed data
likelihood factorizes into QX and g, and consequently, the conditional expectations are
8
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completely determined by QX and g. We also note that we consider here α = α(QX)
as a function of QX . The DR estimating function is given by
ICdr(O|QX , g, h,α) = ICiptw(O|g,α, h)− ICSRA(O|QX , g). (13)
It is shown in Section 1.6 of van der Laan and Robins [2002] that the following double
robustness result holds. This result can also be verified directly as in Yu [2002].
Lemma 2.1. We have EQX ,gICdr(O|Q1, g1, h,α) = 0 if either (g1 = g and (6) holds
at g) or (Q1 = QX and (6) holds at g1).
We note that the estimating function is a function of the observed data O, the causal
parameter α, the choice of h and the nuisance parameters g and QX . As described
above, h can be chosen general, but we will work with the typical choice as provided
in (8). Maximum likelihood estimation of g and QX according to models has been
discussed in previous sections. Given maximum likelihood estimates Qn, hn, and gn of
QX , h, and g, respectively, we define the double robust estimator α̂drn as the solution
of
0 =
1
n
n∑
i=1
ICdr(Oi|Qn, gn, hn,α) (14)
By the double robust property Lemma (2.1), the DR estimator will remain consistent
if either the FX part QX of the likelihood p(O) or g is correctly specified and (6) holds
at the estimated gn.
Implementation of the double robust estimator.
We solve this equation in α with the Newton-Raphson algorithm. In the NR algo-
rithm the derivative is given by cn =
d
dα
1
n
∑n
i=1 ICiptw(Oi|gn,α, h) since ICSRA does
not depend on α. Notice that evaluation of ICdr(Oi|Qn, gn, hn,α) requires evalu-
ating EQn,gn(ICiptw(O|gn,α, h)|Ak,Fk) and EQn,gn(ICiptw(O|gn,α, h)|Fk). We pro-
pose to evaluate these conditional expectations with the following Monte-Carlo sim-
ulation algorithm. Given a subject’s observed history Fk = (a¯k−1, y¯k, l¯k), we fix
a¯∗k−1 = a¯k−1, y¯
∗
k = y¯k, l¯
∗
k = l¯k and now generate the future by sequentially generating
from the factors in the observed data likelihood. Specifically, we generate the future
observation (A(k), Y (k + 1), L(k + 1)) by 1) generating A∗k = a
∗
k from the conditional
distribution of Ak given A¯k−1 = a¯
∗
k−1, Y¯k = y¯
∗
kL¯k = l¯
∗
k, 2) generating Y
∗
k+1 = y
∗
k+1 from
the conditional distribution of Yk+1 given A¯k = a¯
∗
k, Y¯k = y¯
∗
kL¯k = l¯
∗
k, and 3) generat-
ing L∗k+1 from the conditional distribution of Lk+1, given A¯k = a¯
∗
k, L¯
∗
k, Y¯
∗
k+1. Now, set
k = k+1 and repeat till the complete future is observed and thereby the observed data
structure O∗. We can now evaluate ICiptw(O
∗|gn, α̂mln , hn) using this simulated O∗,
estimated gn and MLE α̂
ml
n . We repeat this N times and we use the empirical mean of
ICiptw(O
∗
b |gn, α̂mln , hn), b = 1, . . . , N as our evaluation of EQn,gn(ICiptw(O|gn,α, h)|Fk).
The conditional mean EQn,gn(ICiptw(O|gn,α, h)|Ak,Fk) can be evaluated similarly, ex-
cept that, we start from at the observed past (Ak,Fk). We conclude that, given a fit of
9
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the observed data likelihood QXn(A¯,XA¯)gn(A¯ | X), the implementation of our double
robust estimator is straightforward.
A method for making the double robust estimator more robust.
As we see, in order to calculate the DR estimator, we need, in particular, to model the
distribution of L(tk) given the past and estimate it with MLE. Since Lk is typically a
high dimensional vector in practice, it would be tedious and computationally intensive
to form and fit such a high dimensional likelihood. To simplify the estimation of the
time-specific factors p(L(tk) | L¯(tk−1), Y¯ (tk−1, A¯(tk)) in the partial likelihood QX at
each time point tk, we propose to reduce the multivariate time-dependent covariate
Lk to a univariate time-dependent covariate Ltrt,k extracted from the fitted treatment
mechanism. For example, suppose that the treament value is dichotomous and satisfies
the following logistic regression model:
P (At(tk) = 1|A¯(tk−1), Y¯ (tk), L¯(tk)) = I(Y (tk) = 0)λtk(γ), (15)
where λtk(γ) = logit
−1
(
γ0,k + γ1,kA
t
k−1 + γ
T
2,kLk + γ
T
3,kW
)
. Then we set Ltrt,k ≡ γˆ0,k +
γˆ1,kAk−1 + γˆ
T
2,kLk + γˆ
T
3,kW , where γˆ is the maximum likelihood estimator of γ. Thus
Ltrt,k includes all the information about the observed covariate process which was
considered predictive of treatment assignment. Consider the reduced data structure
O′ ≡ (A¯K , L¯trt,K+1, Y¯K+1). This reduction of the data does not come at cost of a
(increased) violation of SRA since the fit of the treatment model is not affected by this
reduction: we have
P (At(tk) = 1|A¯t(tk−1), Y¯ (tk), L¯(tk)) = logit−1(Ltrt,k), (16)
We proceed to calculate the DR estimator using the Monte-Carlo simulation described
above for this reduced data structure. Because of the data reduction, calculation of
the maximum likelihood estimator of QX is now strongly simplified. We note that this
data reduction does not sacrifice consistency but does reduce the efficiency. However,
possibly much more important in practice, the reduction makes the nuisance parameter
QX much easier to estimate and thereby potentially strongly improves the robustness
of the double robus estimator of α relative to the double robust estimator based on
the complete observed data structure. Having said this, to improve efficiency at cost
of increased computational burden and decreased robustness, one could also include
another univariate covariate extracted from a fitted model of Yj given the past.
2.4 Confidence Intervals
Firstly, we discuss inference when one assumes a correctly specified model for g(A¯|X) so
that Qn → Q1X and gn → g, where Q1X 6= QX is allowed. Under regularity conditions,
the DR estimator α̂drn , defined in equation (14), is a regular asymptotically linear
estimator with influence curve
IC(·) = −c−1 [ICdr(·|Q1, g, h,α)− Π(ICdr(·|Q1, g, h,α)|Tg)] (17)
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where Tg ⊂ TSRA is the tangent space of g under the assumed model for the treatment
mechanism g. For more details we refer to van der Laan and Robins [2002]. We note
that, if Q1X = QX , then the projection term in (17) equals zero.
Since the DR estimator α̂drn is asymptotically linear with influence curve (17), the
asymptotic covariance matrix of α̂drn is given by
Σ̂ =
1
n
n∑
i=1
ÎC(Oi)
⊗2. (18)
One can avoid the calculation of the projection operator on Tg in (17), by estimating
the asymptotic covariance matrix of α̂drn conservatively with
Σ̂ =
1
n
n∑
i=1
ÎCdr(Oi|Qn, gn, hn,α)⊗2. (19)
If Q1X = QX , then the covariance estimates are asymptotically identical.
The above variance estimates can be used to construct a 95% confidence interval
for the j-th component of α given by
α̂
dr
n ± 1.96
Σ̂jj√
n
. (20)
If we only assume that either Qn → QX or gn → g, then we recommend using the
Bootstrap to compute the C.I.
3 Causal Inference for Censored Data
Suppose that the observed data is subject to right censoring and D is the censoring
time. Let At(·) denote the usual treatment process; the superscript t has been added
to emphasize the treatment action. We define a censoring process Ac(tk) = I(D ≤ tk)
and the process A = (At, Ac) will now be defined more generally and refer to both
treatment and censoring. The observed data structure can now be represented as
O = (R = S ∧D, A¯(R) = (A¯t(R), A¯c(R)), X¯A¯t(R)), (21)
where X¯A¯t(·) ≡ (L¯A¯t(·), Y¯A¯t(·)) is the observed history up to R.
We will represent this data structure as a missing data structure on counterfactual
indexed by the joint-action regime a¯. Here it is assumed that the uncensored counter-
factual response and covariate processes are not affected by the actual realization of the
censoring process: that is, in terms of counterfactuals Xa¯(t) = Xa¯t(min(t, d)), where
d is the censoring time corresponding with a¯c. Let A¯, given X, follow a conditional
density which is such that
g(A(tk) | A¯(tk−1), X) = I(SA¯ ≤ tk, DA¯ ≤ tk−1)I(A(tk) = A(tk−1)
+(1− I(SA¯ ≤ tk, DA¯ ≤ tk−1))g(A(tk) | A¯(tk−1), X).
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In words, we truncate the action process at death. Thus At(t) = At(min(t, R)), Ac(t) =
Ac(min(t, R)) so that the process A = (At, Ac) is observable. In this manner, we can
represent the observed data structure (21) as a general censored data structure (A¯,XA¯),
where now the joint regime A = (Ac, At) represents the censoring variable.
The sequential randomization assumption is now given by
g(Ak|A¯k−1, X) = g(Ak|X¯A¯t(tk), A¯k−1). (22)
We have
g(A¯|X) = Πkg
(
Ak|X¯A¯t(tk), A¯k−1
)
= Πkg
(
Ack, A
t
k|X¯A¯t(tk), A¯k−1
)
= Πkg
(
Ack|X¯A¯t(tk), A¯k−1, Atk
)× Πkg (Atk|X¯A¯t(tk), A¯k−1)) . (23)
We construct an Inverse Probability of Action (IPAW) estimator in the same man-
ner as in section 2.1. Here we used the term “Action” to refer to both censoring and
treatment assignments. We simply must extend the stabilized weights to include infor-
mation on the censoring process as well as the treatment process. The IPAW-estimating
function is given by
ICipaw(O|g,α, h) =
∑
k
sw(tk)× I(Ack = 0)× h(tk, A¯tk−1, Y¯k, V )× A¯t(tk | α), (24)
where the stabilized weight is given by
sw(tk) =
g
(
A¯tk, A¯
c
k = 0|V
)
g
(
A¯tk, A¯
c
k = 0|X
)
=
∏k
j=0 g
(
Acj = 0|A¯tj, A¯cj−1 = 0
)∏k
j=0 g
(
Acj = 0|X¯A¯t(tj), A¯tj, A¯cj−1 = 0
)
×
∏k
j=0 g
(
Atj|A¯tj−1, A¯cj−1 = 0, V
)∏k
j=0 g
(
Atj|X¯A¯t(tj), A¯tj−1, A¯cj−1 = 0
) .
(25)
Once again, we can use standard models, such as logistic regression, to fit the censoring
mechanism g
(
Acj = 0|X¯A¯t(tj), A¯tj , A¯cj−1 = 0
)
. Given a choice of h, such as the usual
choice, we can then solve the corresponding estimating equation for α as in section 2.
For example, we can use the S-plus function glm() with weights I(Ack = 0) sw(tk) at
time tk. For details on the implementation we refer to Bryan, Yu, van der Laan (2002).
The action-mechanism orthogonalized estimating function is constructed by sub-
tracting from ICipaw the projection on the tangent space TSRA of the nonparamet-
ric model for g(A¯ | X) defined by (23). Let Fk,c ≡ (X¯A¯t(tk), A¯k−1, Atk) and Fk,t ≡
(X¯A¯t(tk), A¯k−1). We have
ICSRA ≡ Π (ICipaw|TSRA)
=
∑
k
(E (ICipaw|Fk,c, Ack)− E (ICipaw|Fk,c))
+
∑
k
(
E
(
ICipaw|Fk,t, At(tk)
)− E (ICipaw|Fk,t))
12
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In the same manner as we did for the treatment orthogonalized estimating function, we
can consider ICSRA(O | g,Q) as a function of the data O, the action mechanism g and
the partial likelihoodQX . The action orthogonalized estimating function is now defined
by ICao(O | g, α, h,Q) = ICipaw(O | g, α, h) − ICSRA(O | g,Q). Given maximum
likelihood estimators of g and QX , all the condition expectations can be evaluated
with the Monte-Carlo simulation described in the previous section. Again, to simplify
the DR estimation we can reduce L to two time-dependent covariates extracted from
the fitted treatment and fitted censoring mechanisms, as we described in section 2.3.
Details are omitted and presented in our data analysis.
4 A Simulation Study
In this section, we carry out a simulation study to compare various estimators of the
causal parameter α. We consider the IPTW estimator α̂iptwn , the MLE estimator α̂
ml
n
and the DR estimator α̂drn . We compare the estimates by the mean squared error
(MSE), bias and variance across 50 samples of size 250. Corresponding the theory, the
simulations show the following:
• In case that confounding is so severe that the identifiability assumption (6) is
practically violated or the treatment mechanism is misspecified, the finite sample
bias of the DR estimator is much smaller than that of the IPTW estimator.
• If g is correctly specified, the MLE is very sensitive to likelihood misspecification
where as the finite sample bias of the DR estimator remains small.
• If g is correctly specified, the confounding is extreme (so that (6) is practically
violated) and the likelihood is misspecified, then the finite sample bias of the DR
estimator is much smaller than that of the MLE and slightly smaller than that
of IPTW estimator.
• In the case that g is correctly specified, confounding is not extreme, and the
likelihood is correctly specified , the MSE of the DR estimator is smaller than
that of IPTW estimator.
Section 4.1 describes the causal marginal structural model and the treatment mech-
anism we use in the simulation study. Section 4.2 describes how we analyze the sim-
ulated data and thus includes concrete details on implementing all three estimators.
Secton 4.3 compares the MLE based on different models for the likelihood QX . Section
4.4 gives the data-generating parameter values and all of the simulation results.
4.1 Data Generating Model
We use the same simulation setting as in Bryan et al. [2002]. We continue to work in a
discrete time setting, with a finite number of monitoring times. We also use the same
13
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survival counting process introduced earlier. At a given subset of the monitoring times,
we measure a covariate process. The covariate process L(tk) is real-valued and always
positive. We assume that the covariate grows linearly with time until initiation of
treatment and remains unchanged thereafter. The generation of subject-specific slopes
and intercepts is discussed below, as is the effect of treatment on the covariate. At these
measuring times, we may make a change in the treatment and this decision may be a
function of the covariate and treatment history of the subject. The treatment Ak takes
on the values 0 and 1, corresponding to ’off’ and ’on’ treatment, respectively. Once a
subject is on treatment, s/he will remain so until failure. And, of course, a subject will
not be considered for treatment after failure. Given the above considerations, we are
left with a relatively small set of times at which treatment can change. At a treatment
time tk, the probability of initiating treatment is given by the following logistic model:
logit P (Ak = 1 | L¯(tk), A¯k−1 = 0) = θ0 + θ1tk + θ2L(tk). (26)
This is equivalent to the intensity model:
E(dAk|L¯(tk), A¯k−1) = I(A¯k−1 = 0)× logit−1(θ0 + θ1tk + θ2L(tk)).
Therefore partial likelihood estimation can be used to estimate θ, as was mentioned in
section 2. If a subject goes on treatment, we refer to the treatment initiation time as
t∗.
We can now state the MSM. Given a subject that has not failed, the probability of
failure in the upcoming interval is given by
logit(P (Ya¯(tk) = 1 | Ya¯(tk−1) = 0) = α0 + d1(tk)α1 + akα2 + d3(tk)α3, (27)
where d1(tk) = (1 − ak)tk + akt∗ and d3(tk) = ak(tk − t∗). This corresponds to the
intensity model:
λ(tk, a¯, Y¯a¯(tk−1)|α) = I
(
Y¯a¯(tk−1) = 0
)× logit−1 (α0 + d1(tk)α1 + akα2 + d3(tk)α3) .
(28)
We see that the probability of failure depends on the current treatment status ak,
the treatment initiation time t∗ (subjects on treatment), and on either the study time
elapsed tk (subjects off treatment) or the time since treatment initiation tk−t∗ (subjects
on treatment). If there is no treatment effect, α2 = 0 and α1 = α3. All other things
held equal, α2 < 0 corresponds to a positive treatment effect, i.e. treatment causes
a persistent decrease in the hazard. The case α3 < α1 also corresponds to a positive
treatment effect, i.e. treatment causes the hazard to grow more slowly as a function of
time. In a situation where α2 < 0, but α3 > α1, the effect of treatment is ambiguous.
At certain times, it is less hazardous to be on treatment, while at others, it is less
hazardous to be off treatment. In reality, the outcome of interest is survival time Sa¯
and, therefore, we want to find the treatment regime that will maximize, for example,
median survival. Therefore, we will estimate the causal parameter α of the MSM and
estimate median survival for each possible treatment regime. We note that a ’treatment
regime’ in this setting is completely specified by the treatment initiation time. We refer
to Bryan et al. [2002] for a description on how to simulate data from the above model.
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4.2 Analysis of Simulated Data
First we describe the observed data structure. Each subject will exhibit an outcome
of the survival process Y that is a vector of zeros followed by exactly one one, i.e.
something of the form (0, 0, ... , 1). Of the same length as this vector, we will have
the outcome of the covariate and treatment processes. By concatenating this subject-
specific data, we create a dataset from which to estimate the treatment mechanism
and the causal parameter α.
For the details on how to calculate the IPTW estimator based on the simulated
data, we refer to Bryan et al. [2002]. In order to calculate the DR estimator, we need
to estimate the projection term ICSRA(O|QX , g) in the estimating function (13). Given
a fitted Qn, gn, ICSRA(O|Qn, gn) can be calculated using a Monte-Carlo simulation as
we described in section 2.3. QX includes two parts. The first part is the conditional
distribution of Yj given the past and the second part is the conditional distribution
of Lj given the past. In this simulation, given the baseline covariate L0, the future
covariates are degenerate depending on known parameters. So we only need to model
the condition distribution of Yj given the past. We will discuss this in the next section.
4.3 Modelling the Partial Likelihood QX
To compute the DR estimator, we need to assume a model for the distribution of Y (tk)
given (Ak,Fk). In our simulation, we generate Ya¯ satisfying the MSM and set Y ≡ YA¯.
So we actually don’t know the distribution of Y (tk) given (Ak,Fk) for the simulated
data. We also need the MLE α(Q̂X) of α corresponding to the MLE Q̂X) of QX to
calculate the projection term in estimating function (13). In this section, we consider
several candidate models for the law of Y (tk) given (Ak,Fk) and calculate the MLE
of α using the method described in section 2.2. In our simulation model 3 produced
the best MLE for the causal parameter α2. We will use Model 3 to calculate the DR
estimator in our simulation. Note that our model is thus misspecified which represents
a realistic scenario.
Model 1:
logit P (Yk = 1|Y¯k−1 = 0, L¯k, A¯k)
= β0 + β1tk + β2Ak + β3Lk + β4(tk × Ak) + β5(Ak × Lk) (29)
Model 2:
logit P (Yk = 1|Y¯k−1 = 0, L¯k, A¯k)
= β0 + β1tk + β2Ak + β3Lk + β4(Ak × Lk) (30)
Model 3:
logit P (Yk = 1|Y¯k−1 = 0, L¯k, A¯k) = β0 + β1tk + β2Lk + β3(Ak × Lk) (31)
Table 1 summarizes the bias and MSE of the maximum likelihood estimates for α
based on these three models.
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Bias Var MSE
MLE1 0.292 0.014 0.099
α0 MLE2 0.316 0.010 0.109
MLE3 0.625 0.006 0.397
MLE1 0.063 0.001 0.005
α1 MLE2 0.046 0.001 0.003
MLE3 0.023 0.001 0.001
MLE1 1.654 0.134 2.870
α2 MLE2 1.677 0.143 2.954
MLE3 0.133 0.041 0.058
MLE1 0.175 0.003 0.033
α3 MLE2 0.185 0.003 0.037
MLE3 0.078 0.001 0.007
Table 1: Bias, Variance and MSE of MLE’s (200 replicates)
4.4 Simulation Results
In all of the simulations described below, the study takes place over time interval [0,20].
The monitoring times are {t0 = 0, t1 = 1, . . . , t19 = 19}. We measure the covariate once
in every five intervals, therefore the measuring times are {t0, t5, t10, t15}. The treatment
times are t0 and t5. Therefore the set of possible treatment paths is given by
A = {(a0, a5) : a0, a5 ∈ {0, 1}, a0 ≤ a5} = {(0, 0), (0, 1), (1, 1)}. (32)
The value of α, the parameter of the logistic MSM given in equation (27), is given by
α0 α1 α2 α3
-3.04 0.175 -1.5 0.388
Since α2 < 0 and α1 > α3, there is a treatment effect. In fact, we are in one of the
ambiguous situations described in section 4.1, in which it is not immediately apparent
which treatment strategy is best. In the implementation of the IPTW estimator we
truncate the weights. That is, if the weight is greater than 3 we set it to be 3. We
report the bias and mean squared error (MSE) of α2 for Naive, IPTW MLE and DR
estimators in table 2. Recall that in our marginal structura model α2 is our primary
parameter of interest.
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DR IPTW MLE Naive
Simulation 1: confounding is extreme, truncation of weights
of weights at 3 and Model 3 for the likelihood
Bias 0.06 0.649 0.143 2.059
MSE 0.627 1.216 0.058 4.362
Simulation 2: g is misspecified and Model 3
for the likelihood
Bias 0.004 0.323 0.188 0.353
MSE 0.025 0.191 0.063 0.209
Simulation 3: g is correctly specified and Model 4
for the likelihood
Bias 0.002 0.032 1.464 0.377
MSE 0.054 0.059 2.167 0.227
Simulation 4: confounding is extreme and Model 4
for the likelihood
Bias 0.499 0.768 1.901 1.940
MSE 0.645 0.855 3.642 3.858
Simulation 4: confounding is normal and Model 3
for the likelihood
Bias 0.0054 0.0214 0.1550 0.3377
MSE 0.0251 0.0413 0.0456 0.1660
Table 2: Finite sample bias and MSE of α2 for all the estimators in the 5 simulation
settings
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4.4.1 Simulation 1
The main point of this simulation is to show the relative performance of the IPTW,
double robust and ML estimators in case that the confounding is so severe that the
identifiability assumption is practically violated. The presence and degree of confound-
ing is completely determined by the parameter θ in model (26).
The first value of θ we consider in this simulation is θ = (−6.7, 0, 0.5). (if w = 30
which is the maximum baseline covariate seen in one simulation, then the probability
of getting treatment 0 is 1/(1 + exp(8.3)) = 0.00025). We truncate the weights at 3.
The finite sample bias of the IPTW estimate is large because the truncation of the
weights makes the IPTW estimating function biased even though we use a correctly
specified model for g. Because of the truncation, this case corresponds with actually
choosing a wrong model for the treatment mechanism g. We will see in the other
simulations that the truncation does not affect the unbiasedness of the IPTW estimate
when the confounding is not extreme. The finite sample bias of the DR estimate
remains small since the DR estimating function remains unbiased at correctly specified
likelihood and misspecified g. In fact, the finite sample bias of the DR is significantly
smaller than the bias of DR. It was interesting to see that the finite sample bias of the
DR estimate is much smaller than that of the MLE for α0 and α3, not reported here.
The difference in MSE between the IPTW, the DR estimate, and the MLE is
significant, with the MLE being a clear winner. We note that the variance of the MLE
is supposed to be smaller than the variance of the DR, since the MLE assumes a smaller
model.
4.4.2 Simulation 2
In this simulation we will show the relative performance of the four estimators when the
treatment model is misspecified. We use the following misspecified treatment model:
logit P (Ak = 1 | L¯k, A¯k−1 = 0) = θ0 + θ1tk + θ2 sin(Lk). (33)
In other words, we regress on sin(Lk) instead of Lk. The value of θ we use for this
simulation is θ = (−0.9, 0, 0.04).
We note that the finite sample bias of the DR estimate is much smaller than that
of the IPTW estimate. This is due to the protection against misspecification of g at a
correctly specified likelihood QX . The bias of DR is also smaller than the bias of the
MLE.
The difference in MSE for α2 between the IPTW and DR estimates is dramatic in
this case, while the DR estimator now heavily outperforms the MLE.
4.4.3 Simulation 3
In this simulation, we will show the relative performance of the four estimators when
the likelihood for Yk given the past is misspecified. We use the following misspecified
model to estimate the distribution of Yk given the past.
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Model 4
logitP (Yk = 1|Y¯k−1 = 0, L¯k, A¯k) = β0 + β1Ak + β2Lk + β3(Ak × Lk) (34)
Note that we deleted the tk term in Model 4 from Model 2. The value of θ for this
simulation is same as simulation 2: θ = (−0.9, 0, 0.04).
We note that the finite sample bias of the DR estimate is much smaller than that of
the MLE. This is due to the fact that, at correctly specified treatment mechanism, the
consistency of the DR estimator is protected against misspecification of the likelihood
The finite sample MSE of the DR estimate for α2 is slightly smaller than that of
the IPTW estimate while it is 40 times as small than the MSE of the MLE.
4.4.4 Simulation 4
In this simulation, we consider the case where confounding is extreme and the likelihood
QX is misspecified. The value we choose for θ is the same as in simulation 1, θ =
(−6.7, 0, 0.5). We use model (34) to estimate the distribution of Yk given the past.
In this case, all the estimates are supposed to be inconsistent and thus biased. We
note that the DR estimate is the least biased and most efficient, and the MLE is heavily
biased.
4.4.5 Simulation 5
In this last simulation we set the confounding at a normal level θ = (−0.9, 0, 0.04) and
assume Model 3 for the likelihood so that it is approximately correctly specified.
In this case, both the IPTW and the DR estimates are known to be asymptotically
consistent. We note that the finite sample MSE of the DR estimate is smaller than
that of the IPTW estimate, and the MLE is by far the most biased estimator. This
shows that a bias in the MLE due to slight misspecification of the model for QX does
result in much less of a bias in the DR estimator.
5 Analysis of SPARCS Data
Here we apply the methodology developed in previous sections to analyze data from
a project entitled “Study of Physical Performance and Age Related Changes in Sono-
mans” (SPARCS) [Tager et al., 2000b]. SPARCS is a community-based longitudinal
study of physical activity and fitness in people at least 55 years of age who live in
Sonoma, California. One of the goals of SPARCS and the primary goal of the cur-
rent analysis is to estimate the causal effect of increased physical activity on physical
functioning.
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5.1 Data Structure
The subset of the data that we examine here was collected in the first three home
evaluations of female SPARCS participants n = 947, over the time period May, 1993 -
1999.
Our measure of physical activity (at) is based on an activity score that is recorded
for each subject at each evaluation. The activity score takes values in the set {1, 2, 3, 4},
where 4 corresponds to the highest level of activity. We define a time-dependent treat-
ment process At(tk) that is an indicator for an activity score of 3 or 4 during the interval
(tk, tk+1), which implies that the subject is engaging in moderately vigorous activity.
Note that, although subjects are not being actively treated in any way, we can simply
handle a subject’s self-chosen activity level as an intervention whose efficacy we wish
to measure.
The outcome of interest (y), physical functioning, is recorded for each subject at
each evaluation. It is a dichotomous variable with 1 indicating ”disabled”.
At the initial evaluation, information on the the following baseline covariates is
obtained: age in years (age), indicator of activity decline in past 5 - 10 years, Bmass2,
Bmass3. This collection of variables is referred to collectively as W . At each evalu-
ation, including the baseline evaluation, information on the following time-dependent
covariates is obtained: indicator of other health conditions, Ln2Fat, Q1D, Speed, Dps2,
Along, other These variables will be referred to collectively as Lk.
One expects that the variables W and Lk can influence both the activity level and
the physical functioning. Therefore, we must regard W and Lk as potential confounders
in our study of the causal relationship between activity level and physical functioning.
The data we study here is different from what we study in the simulation. There
are only three time point: t0, t1 and t2. The treatments, covariates and outcomes are
measured at each time point until the subject drops out or dies. So there are two types
of censoring. We refer to the censoring time as D which is the minumum of death and
dropout time. Of the 1197 participants, each subject accumulates a history until the
earliest of these events: end-of-study K = 2, or censoring D.
We use the following rules to deal with missing values: the subjects were excluded
from the analysis as a result of missing baseline info for 1 or more of the following:
Ln2Fat (extreme outliers), decline, bmass, overall health, Q1D. Other subjects were
treated as right censored in the analysis from the moment there was missing informa-
tion.
5.2 Causal Models
The full data for a subject includes the uncensored outcome (physical functioning) and
covariate processes for every possible treatment regime is
X = (Y¯a¯t(tK), L¯a¯t(tK),W ; a¯
t ∈ At),
where K = 2. In contrast, the observed data includes the outcome and covariate
processes corresponding to the subject’s actual treatment history possibly subject to
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censoring:
O = (R = tK ∧D, A¯t(R), Y¯ (R), L¯(R),W )
We consider the following Marginal Structural Model for Y¯a¯t
P (Ya¯t(tk) = 1) = α0 + α1tk + α2a
t
k
In order to compute the IPTW estimator, we must model the treatment and censoring
mechanisms to form the weights. We assume the following logistic regression model for
the treatment mechanism:
P (Atk = 1|A¯tk−1, L¯k,W ) = λtk(γ), (35)
where λtk(γ) = logit
−1
(
γ0,k + γ1,kA
t
k−1 + γ
T
2,kLk + γ
T
3,kW
)
. The usual partial mle γ can
be computed using standard software and we compute the treatment contribution to
the estimated weights as described before in section 4.2.
We do not assume that the drop-out time D is independent of survival, but we
do assume that D is independent conditional on the observed covariate history as in
section 3. Therefore, our weights will include the probability of not being censored
due to dropout, in addition to the above probability on the treatment mechanism. We
define a drop-out censoring process Ack = I(D ∈ (tk, tk+1)). If the subject drops out
before death or end of the study, A¯c = (0, . . . , 0, 1); otherwise A¯c = (0, . . . , 0, 0). We
assume the following intensity model for the drop-out process:
E(dAck|L¯k,W, A¯tk, A¯ck−1) = I(A¯ck−1 = 0)× pitk(β), (36)
where pik(β) = logit
−1
(
β0,k + β1,kA
t
k + β
T
2,kLk + β
T
3,kW
)
. Just as with the treatment
process, we fit the regression implied by (36). Denote the estimator by β̂ and the
implied probability of dropout at time tk for subject i by q̂ik. The same quantities, but
based on a regression in which L¯k is omitted as a predictor, are denoted by β˜ and q˜ik.
The censoring contribution to the estimated stabilized weight is then
k∏
j=0
(1− q˜ij)
(1− q̂ij)
The treatment contribution is calculated as it was earlier in the simulations and the
estimated stabilized weights are an element-wise product of treatment and censoring
terms.
To simplify the estimation of ICSRA, as we described in section 2.3, at each time
point, we extract two covariates from the fitted treatment and censoring mechanisms
respectively. The first covariate Ltrt,k ≡ γˆ0,k + γˆ1,kAtk−1 + γˆT2,kLk + γˆT3,kW includes all
the information contributing to the treatment mechanism. The treatment model now
simply becomes
P (Atk = 1|A¯tk−1, L¯k,W ) = logit−1(Ltrt,k), (37)
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Intercept Time Treatment
α̂
dr
n -0.873 0.071 -0.126
(0.097) (0.059) (0.109)
α̂
iptw
n -0.908 0.182 -0.089
(0.100) (0.053) (0.117)
α̂
ml
n -1.339 0.624 -0.139
α˜n -0.753 0.116 -0.364
Table 3: Data analysis results of four different estimators
The other covariate Lcen,k ≡ βˆ0,k + βˆ1,kAtk + βˆT2,kLk + βˆT3,kW, includes the information
contributing to the censoring covariates. Now the censoring model becomes
E(dAck|L¯k,W, A¯tk, A¯ck−1) = I(A¯ck−1 = 0)× logit−1(Lcen,k). (38)
In the reduced data, at each time point there are only two covariates Ltrt,k and Lcen,k.
To compute the MLE and ICSRA, we need the conditional distributions of Yk given the
past, Lcen,k given the past and Ltrt,k given the past. At each time point, we assume the
distribution of Ltrt,k given the past is normally distributed with mean equal to a linear
function of Yk−1, Ltrt,k−1 and A
t
k−1, the distribution of Lcen, k given the past is normal
with mean equal to a linear function of Ltrt,k, Lcen,k−1 and A
t
k−1, the distribution of Yk
given the past is linear logistic function with covariates Atk, Ltrt,k, Lcen,k and Yk−1. We
use maximum likelihood to estimate the parameters. The details on computing α̂mln
and ICSRA using Monte-Carlo simulation were described previously.
5.3 Results
Table 3 reports the estimate of α based on the DR, IPTW, MLE and Naive estimators.
The conservatively estimated standard errors described in Section 2.4 of the DR and
the IPTW estimators are reported in parentheses.
The data analysis suggest that physical activity decreases the probability of being
disabled in physical functioning. This effect is seen in all of the four estimators. But
for both the DR and the IPTW estimates, the effect is not statistically significant. We
also note that the DR estimator is closer to the IPTW than to the MLE. This might
be due to misspecification of the partial likelihood QX .
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